Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 23

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04785287Phase 1/2Terminated
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
PrincipalinvestigatorStart date: 2021-03-29
NCT02710253Phase 2Completed
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2016-05-25
NCT02444741Phase 1/2Completed
Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
PrincipalinvestigatorStart date: 2015-09-17
NCT02402920Phase 1Completed
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung CarcinomaNeuroendocrine Neoplasm
PrincipalinvestigatorStart date: 2015-07-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+8 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score14%

Arya Amini

City of Hope Medical Center

Related
7 trials

Shared therapeutic areas:

Stage IV Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Malignant Solid Neoplasm+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+7 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score13%

Kathrin Milbury

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+6 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score11%

Anurag K Singh

Roswell Park Cancer Institute

Related
8 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmStage III Lung Cancer AJCC v8+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Virginia Sun

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Malignant Solid NeoplasmStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Zhongxing Liao, MD

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmMetastatic Lung Non-Small Cell Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Malignant Adrenal Gland NeoplasmMalignant Solid NeoplasmNeuroendocrine Neoplasm+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04785287Phase 1/2PrincipalInvestigator

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
Terminated
NCT02710253Phase 2PrincipalInvestigator

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
Completed
NCT02444741Phase 1/2PrincipalInvestigator

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
Completed
NCT02402920Phase 1PrincipalInvestigator

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung CarcinomaNeuroendocrine Neoplasm
Completed

All 4 trials loaded